Product Information
BLEOMYCIN SULFATE 15 UNIT VIAL is a generic product labeled by Fresenius Kabi USA, LLC, priced at $26.4480 per EA under NDC 63323013610. Its NADAC has been published 80 times since Dec 18, 2024.
Strength
15 [USP'U]/1
Manufacturer
Fresenius Kabi USA, LLCNDC
63323013610
Classification
Generic
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAMUSCULAR; INTRAPLEURAL; INTRAVENOUS; SUBCUTANEOUS
Last Updated
4/22/2026
Active Ingredients
BLEOMYCIN SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA065185On Market Since
2/13/2009
Pharmacological Classes
Price Statistics
The NADAC for BLEOMYCIN SULFATE 15 UNIT VIAL has been published 80 times since Dec 18, 2024, and over the history we have for it it has declined 16.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $26.4480 per EA |
|---|---|
| All-time high | $31.7820 (Dec 10, 2025) |
| All-time low | $24.0040 (Dec 17, 2025) |
| 52-week high | $31.7820 |
| 52-week low | $24.0040 |
| Median price | $31.7820 |
| Average price | $29.4823 |
| Largest weekly change | -24.5% (Dec 17, 2025) |
| Weeks tracked | 80 |
| Tracking since | Dec 18, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the BLEOMYCIN SULFATE market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of BLEOMYCIN SULFATE 15 UNIT VIAL?
The current National Average Drug Acquisition Cost (NADAC) for BLEOMYCIN SULFATE 15 UNIT VIAL, manufactured by Fresenius Kabi USA, LLC, is $26.4480 per EA (NDC 63323013610), effective Jun 24, 2026.
How has the price of BLEOMYCIN SULFATE 15 UNIT VIAL changed over time?
Over the history we have for it, the NADAC for BLEOMYCIN SULFATE 15 UNIT VIAL has declined 16.8%. It has been tracked across 80 weekly CMS publications since Dec 18, 2024.
What are the highest and lowest recorded NADAC prices for BLEOMYCIN SULFATE 15 UNIT VIAL?
Since Dec 18, 2024, the NADAC for BLEOMYCIN SULFATE 15 UNIT VIAL has ranged from a low of $24.0040 (Dec 17, 2025) to a high of $31.7820 (Dec 10, 2025), with a median of $31.7820 per EA.
Are there cheaper alternatives to BLEOMYCIN SULFATE 15 UNIT VIAL?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of BLEOMYCIN SULFATE 15 UNIT VIAL, so no direct lower-cost alternative is listed.
Who manufactures BLEOMYCIN SULFATE 15 UNIT VIAL?
BLEOMYCIN SULFATE 15 UNIT VIAL (NDC 63323013610) is labeled by Fresenius Kabi USA, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification